£107.98

Humana Cerebral Signal Transduction: From First to Fourth Messengers (Contemporary Neuroscience)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£108 today · all-time low £107 (Feb 2026) · usually £111

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£112.97 £106.40 £107.84 £109.27 £110.70 £112.13 £113.57 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 5 price levels

Days at Price
Current Price
2 days 6 days · current 15 days 52 days 15 days 0 13 26 39 52 £107 £108 £110 £111 £113 Days at Price

Price Analysis

Most common price: £111 (52 days, 57.8%)

Price range: £107 - £113

Price levels: 5 different prices over 90 days

Description

Since the pioneering discovery of cyclic AMP four decades ago, a multitude of signaling pathways have been uncovered in which an extracellular signal (first messenger) impacts the cell surface, thereby triggering a cascade that ultimately acts on the cell nucleus. In each cascade the first messenger gives rise to the appearance of a second messenger such as cyclic AMP, cyclic GMP, or diacylglycerol, which in turn triggers a third messenger, a fourth messenger, and so forth. Many advances in elucidating such pathways have been made, including efforts to link messenger molecules to brain processes operative in health or disease. However, the latter type of information, relating signaling pathways to brain function, is scattered across a variety of publication media, which makes it difficult to integrate the multiple roles of different signaling cascades into our understanding of brain function in health and disease. The primary aim of Cerebral Signal Transduction: From First to Fourth Messengers, therefore, is to offer a comprehensive picture of the recent advances made in the signaling field as it relates to neuronal and cere bral function. The current state of progress provides an exciting opportunity for such a comprehensive focus because molecular tools have become available to selectively remove, reduce, or enhance spe cific components in the signaling pathways, e. g. , by interfering with the genes encoding key proteins. In addition, the increased awareness of crosstalk between different signaling cascades has revealed many possibilities for changes in gene expression underlying long-term changes in brain function.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)
81% match

Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)

Humana

£110.39 18 May 2026
Stem Cells and CNS Development (Contemporary Neuroscience)
80% match

Stem Cells and CNS Development (Contemporary Neuroscience)

Humana

£107.98 18 May 2026
Neurotrophic Factors: 25 (Neuromethods, 25)
80% match

Neurotrophic Factors: 25 (Neuromethods, 25)

Humana

£107.98 18 May 2026
Nanoscale Imaging of Synapses: New Concepts and Opportunities: 84 (Neuromethods, 84)
80% match

Nanoscale Imaging of Synapses: New Concepts and Opportunities: 84 (Neuromethods, 84)

Humana

£107.98 18 May 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
80% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.11 18 May 2026
The Ionotropic Glutamate Receptors (The Receptors)
80% match

The Ionotropic Glutamate Receptors (The Receptors)

Humana

£108.61 18 May 2026
Neuroimaging of Movement Disorders: 44 (Current Clinical Neurology, 44)
79% match

Neuroimaging of Movement Disorders: 44 (Current Clinical Neurology, 44)

Humana

£103.24 18 May 2026
Discoveries in the Human Brain: Neuroscience Prehistory, Brain Structure, and Function
79% match

Discoveries in the Human Brain: Neuroscience Prehistory, Brain Structure, and Function

Humana

£113.04 19 May 2026
Computational Neuroanatomy: Principles and Methods
79% match

Computational Neuroanatomy: Principles and Methods

Humana

£108.92 18 May 2026
Neurotransmitter Interactions and Cognitive Function
79% match

Neurotransmitter Interactions and Cognitive Function

Birkhauser

£76.01 11 May 2026
The NMDA Receptors: 30 (The Receptors, 30)
79% match

The NMDA Receptors: 30 (The Receptors, 30)

Humana

£107.84 18 May 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
79% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£121.64 18 May 2026
Protocols in Molecular Neurobiology: 13 (Methods in Molecular Biology, 13)
79% match

Protocols in Molecular Neurobiology: 13 (Methods in Molecular Biology, 13)

Humana

£76.05 18 May 2026
Neurointervention in the Medical Specialties: A Comprehensive Guide (Current Clinical Neurology)
79% match

Neurointervention in the Medical Specialties: A Comprehensive Guide (Current Clinical Neurology)

Humana

£80.64 18 May 2026
Calcium Measurement Methods: 43 (Neuromethods, 43)
78% match

Calcium Measurement Methods: 43 (Neuromethods, 43)

Humana

£103.24 18 May 2026
Current Proteomic Approaches Applied to Brain Function: 127 (Neuromethods, 127)
78% match

Current Proteomic Approaches Applied to Brain Function: 127 (Neuromethods, 127)

Humana

£103.24 18 May 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
78% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£59.42 18 May 2026
Lateralized Brain Functions: Methods in Human and Non-Human Species (Neuromethods, 217)
78% match

Lateralized Brain Functions: Methods in Human and Non-Human Species (Neuromethods, 217)

Humana

£162.17 16 May 2026
Computational Neuroscience: 199 (Neuromethods, 199)
78% match

Computational Neuroscience: 199 (Neuromethods, 199)

Humana

£92.94 04 May 2026
Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)
78% match

Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (Current Clinical Neurology)

Humana

£80.65 11 May 2026
Stimulation and Inhibition of Neurons: 78 (Neuromethods, 78)
78% match

Stimulation and Inhibition of Neurons: 78 (Neuromethods, 78)

Humana

£80.64 18 May 2026
Cytokines and the Brain: Volume 6 (NeuroImmune Biology, Volume 6)
78% match

Cytokines and the Brain: Volume 6 (NeuroImmune Biology, Volume 6)

Elsevier

£137.49 18 May 2026
Molecular Neurobiological Techniques: 16 (Neuromethods, 16)
77% match

Molecular Neurobiological Techniques: 16 (Neuromethods, 16)

Humana

£104.31 16 May 2026
Identification, Characterization, and Manipulation of Neuronal Ensembles (Neuromethods, 215)
77% match

Identification, Characterization, and Manipulation of Neuronal Ensembles (Neuromethods, 215)

Humana

£95.70 18 May 2026